NASDAQ: IDXX · Health Care / Biotechnology: In Vitro & In Vivo Diagnostic Substances

IDEXX Laboratories Inc.

How IDEXX Laboratories Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$45.4B

Price

$575.98

P/E

39.9

EPS (TTM)

$14.45

1-year return

-8.4%

Dividend yield

0.0%

52-week range

$504.70–$766.68

Compared with

• Biotechnology: In Vitro & In Vivo Diagnostic Substances industry
• Health Care sector
• S&P 500
• NASDAQ-100

For information only, not investment advice. Data may contain errors. Disclaimer · Sources